Quadrise Plc (LON: QED), the supplier of innovative energy solutions for a cleaner planet, is delighted to announce the signature of a Collaboration and Operational Trial Agreement with MSC Shipmanagement Ltd (MSC) and Cargill NV (Cargill), paving the way for the long-awaited vessel trials on board the MSC Leandra.
Further to the Company’s announcement of 10 July 2024, and under the Project Agreement, Quadrise, MSC and Cargill have agreed their respective obligations under which the Company’s fuels, bioMSAR™ and MSAR®, will be produced at the MAC2 facility in Antwerp, Belgium using feedstocks supplied by Cargill and then sold by Cargill to MSC for the Trials.
The parties to the Project Agreement will use their reasonable endeavours to contribute towards the successful Trials and to receipt of a final Letter of No Objection from Wärtsilä following 4,000 hours of bioMSAR™ testing, with:
· Quadrise providing equipment, additives and technical expertise; and
· MSC providing the trial vessel, MSC Leandra, necessary flag state approvals for the Trials and procuring professional monitoring services for the Trials; and
· Cargill providing the necessary feedstocks, transportation of fuels and operational and logistical support.
